Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young International Inc. (Nasdaq: SY) announced updates regarding its status under the Holding Foreign Companies Accountable Act (HFCAA) after being identified by the SEC on May 9, 2022. The identification stems from the use of a public accounting firm whose working papers cannot be fully inspected by the PCAOB for the fiscal year ending December 31, 2021. If identified for three consecutive years, So-Young's shares could be prohibited from trading in the U.S. The Company is actively seeking solutions to protect stakeholder interests and intends to comply with all applicable regulations to maintain its Nasdaq listing.
So-Young International Inc. (Nasdaq: SY), a leading social community in China's medical aesthetics sector, has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021, with the SEC on May 2, 2022. The report is accessible on the Company's investor relations website. Shareholders can request a hard copy of the report, including audited financial statements, at no charge. So-Young aims to leverage its brand and user trust to expand in the medical aesthetics industry and the broader healthcare market.
So-Young International Inc. (SY) reported its fourth quarter and fiscal year 2021 financial results. Total revenues for Q4 reached RMB449.5 million (US$70.5 million), a 5.9% increase year-over-year. However, the company experienced a net loss of RMB27.7 million (US$4.4 million) compared to a profit of RMB38.6 million in Q4 2020. For the full year, revenues grew 30.7% to RMB1,692.5 million (US$265.6 million), but net loss was RMB8.4 million (US$1.3 million) against a profit in FY 2020. The company anticipates Q1 2022 revenues to decrease by 16.6% to 19.4% due to ongoing market uncertainties.
So-Young International Inc. (NASDAQ: SY) will release its financial results for Q4 and the full year ended December 31, 2021, on March 25, 2022, before U.S. markets open. The company is the leading social community in China's medical aesthetics sector, offering trustworthy content and a platform that connects consumers with vetted service providers. With a strong brand image and engaging community, So-Young aims to expand in both the medical aesthetics and fast-growing healthcare service markets.
So-Young International Inc. (Nasdaq: SY) announced that its board's special committee has engaged Duff & Phelps and Gibson, Dunn & Crutcher LLP to evaluate a non-binding proposal from CEO Xing Jin. The offer proposes to acquire all outstanding Class A shares not already owned by him for $5.30 per American Depositary Share (ADS). The company cautions that this proposal is preliminary, with no binding commitments made yet, and no decisions have been reached regarding the transaction. Shareholders are advised that no action is required at this time.
So-Young International Inc. (Nasdaq: SY) announced a non-binding proposal from CEO Xing Jin to acquire all outstanding Class A ordinary shares not owned by him for $5.30 per ADS or $6.89 per share in cash. This represents a premium of approximately 22.7% over the closing price on November 19, 2021. The company's board has formed a special committee of independent directors to evaluate the proposal, with no decisions made at this stage. There is no assurance that the acquisition will proceed, as it hinges on further negotiations and definitive agreements.
So-Young International Inc. (Nasdaq: SY) reported its third quarter 2021 financial results, achieving total revenues of RMB431.5 million (US$67.0 million), a 20.0% year-over-year increase. Net income surged 649.5% to RMB6.8 million (US$1.1 million), while non-GAAP net income rose 9.6% to RMB28.9 million (US$4.5 million). Despite a decline in average mobile MAUs to 8.0 million, the number of paying medical service providers grew 18.2% to 4,841. The Company anticipates fourth-quarter revenues between RMB430 million and RMB450 million, reflecting a potential increase of up to 6.0% compared to 2020.
So-Young International Inc. (NASDAQ: SY) will release its third-quarter financial results for the period ending September 30, 2021, before U.S. markets open on November 19, 2021. An earnings conference call will follow at 7:00 AM EST, with preregistration required due to COVID-19 restrictions. So-Young continues to position itself as a leader in China's medical aesthetics industry, offering a vibrant social community and reliable information to users.
So-Young International Inc. (SY) reported second quarter 2021 revenues of RMB451.8 million (US$70.0 million), up 37.7% from RMB328.2 million in Q2 2020, exceeding prior guidance. Net income reached RMB57.6 million (US$8.9 million), a 26-fold increase year-over-year, while non-GAAP net income grew by 145.2% to RMB73.7 million (US$11.4 million). Average monthly active users rose by 47.5% to 10 million, and paying medical service providers increased by 31.2% to 4,899. The company expects Q3 revenues between RMB430 million and RMB450 million, reflecting continued growth prospects despite potential COVID-19 impacts.
So-Young International Inc. (NASDAQ: SY) will release its financial results for Q2 ended June 30, 2021, before U.S. markets open on September 10, 2021. A management conference call will occur at 7:30 AM U.S. Eastern Time the same day. Due to COVID-19, operator-assisted calls are unavailable; preregistration is required. So-Young is a leading social community in China's medical aesthetics sector, providing reliable information and curated service providers, positioning itself for growth in both aesthetic and healthcare service markets.
FAQ
What is the current stock price of So-Young Intl (SY)?
What is the market cap of So-Young Intl (SY)?
